Table 3 Cytotoxicity activity of l-glutaminase produced by Bacillus sp. DV2-37 against human breast (MCF-7), hepatocellular (HepG2), and colon (HCT-116) carcinoma cells
From: Production, characterization, and antitumor efficiency of l-glutaminase from halophilic bacteria
l-glutaminase concentration (µg/ml) | Viability (%) | ||
|---|---|---|---|
MCF-7 | Hep G-2 | HCT-116 | |
50 | 8.97 | 6.89 | 9.83 |
25 | 15.91 | 11.93 | 14.47 |
12.5 | 24.59 | 20.47 | 23.65 |
6.25 | 39.42 | 35.29 | 35.54 |
3.125 | 51.47 | 51.43 | 53.92 |
1.56 | 74.92 | 82.94 | 68.17 |
0 | 100 | 100 | 100 |